In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OEHHA

This article was originally published in The Rose Sheet

Executive Summary

Propylene glycol mono-t-butyl ether, a chemical used as a solvent in nail polish lacquers, cleaners and other water-reducible coatings, has been added to the California Prop 65 list of chemicals known to the state to cause cancer, Office of Environmental Health Hazard Assessment reports. Agency issued a notice of intent to list the chemical in April, citing an NTP study as its basis. Last year, NTP reviewed a technical report on propylene glycol mono-t-butyl ether and determined there is "equivocal evidence" of carcinogenic activity of the chemical in F344/N rats in a two-year inhalation study (1"The Rose Sheet" April 21, 2003, p. 7)...

You may also be interested in...



TEA Carcinogenic Link Suggested By Two Year NTP Study

Triethanolamine demonstrated "some evidence" of carcinogenic activity in a two-year dermal study of female B6C3F1 mice and "equivocal evidence" of carcinogenic activity in male mice, the National Toxicology Program states in a 1draft technical report on the ingredient

Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line

The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.

Global Pharma Guidance Tracker – March 2024

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012246

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel